Protective anti-chlamydial vaccine regimen-induced CD4+ T cell response mediates early inhibition of pathogenic CD8+ T cell response following genital challenge

We have demonstrated previously that TNF-alpha-producing CD8(+) T cells mediate chlamydial pathogenesis, likely in an antigen (Ag)-specific fashion. Here we hypothesize that inhibition of Ag-specific CD8(+) T cell response after immunization and/or challenge would correlate with protection against oviduct pathology induced by a protective vaccine regimen. Intranasal (i.n.) live chlamydial elementary body (EB), intramuscular (i.m.) live EB, or i.n. irrelevant antigen, bovine serum albumin (BSA), immunized animals induced near-total protection, 50% protection, or no protection, respectively against oviduct pathology following i.vag. C. muridarum challenge. In these models, we evaluated Ag-specific CD8(+) T cell cytokine response at various time-periods after immunization or challenge. The results show protective efficacy of vaccine regimens correlated with reduction of Ag-specific CD8(+) T cell TNF-alpha responses following i.vag. chlamydial challenge, not after immunization. Depletion of CD4(+) T cells abrogated, whereas adoptive transfer of Ag-specific CD4(+) T cells induced the significant reduction of Ag-specific CD8(+) T cell TNF-alpha response after chlamydial challenge. In conclusion, protective anti-chlamydial vaccine regimens induce Ag-specific CD4(+) T cell response that mediate early inhibition of pathogenic CD8(+) T cell response following challenge and may serve as a predictive biomarker of protection against Chlamydia -induced chronic pathologies.